Kesar India Ltd
543542Kesar India Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +94.8% in a year while annual EPS moved +33.6% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (49 weeks in) while the P/E sits at the 21st percentile of its own 2-year range. Underneath, the last four quarters read mixed, and −212% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Kesar India Ltd trades at ₹1,266, in a confirmed uptrend and 49 weeks into that stage. That is +12.2% against its own 200-day average. It sits at 99% of a 52-week range of ₹711 to ₹1,269. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (4 weeks and counting).
Today the stock is in a confirmed uptrend — week 49 of stage 2, confirmed. At ₹1,266 it trades +12.2% versus its 200-day average and sits at 99% of its 52-week range (₹711–₹1,269).
Against the market, two honest reads. Cumulative: over the last 4.1 years the stock moved +5,040% while the NIFTY 500 moved +67% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (4 weeks and counting; last ahead the week of 2026-07-17) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Kesar India Ltd trades at 84.6× P/E, near the bottom of its own range — cheaper only 21% of the time. Its long-run median P/E is 118.8×, measured across 2.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 84.6× is near the bottom of its own range — cheaper only 21% of the time, against a long-run median of 118.8× measured over 2.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved +33.6% against a +94.8% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Kesar India Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +63.0% | +127.2% | +173.0% | — |
| Profit | +57.9% | +210.7% | +395.9% | — |
| EPS | +33.6% | +219.7% | +83.7% | — |
| Share price | +94.8% | +261.7% | — | — |
4-Factor Sector Score
54.0/100 — rank 8 of 26 in Realty - Construction & Contracting · 67% evidence confidence
Kesar India Ltd scores 54.0 out of 100 against the 26 companies it is compared with in Realty - Construction & Contracting, ranking 8. Price leads the evidence: RS versus the benchmark is 16%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 14.7 + 17.3 + 8.8 + 13.2 = 54. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Kesar India Ltd reported ₹171 Cr of revenue in the Jun 26 quarter, +1,040.0% year on year. That is the 3rd straight quarter of year-on-year growth. Over 7 years it has compounded at 165.4% a year. The last full year, FY26, came in at ₹176 Cr. The last four reported quarters add to ₹363 Cr.
FY26 revenue came in at ₹176 Cr (+63.0% on the year), capping 7 years at 165.4% compound. The latest quarter (Jun 26) printed ₹171 Cr, +1,040.0% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +379.5% growth against the decade's 165.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +192.8% over the last 4 quarters against +130.0%/yr over the last 8 — accelerating; TTM profit +129.4% vs +101.2%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Kesar India Ltd's operating margin is 8.0% in the Jun 26 quarter, −6.0 percentage points against the same quarter a year ago. Across 8 fiscal years the operating margin has ranged −6.3% to 55.4%. The current quarter sits inside that band.
The latest quarter's operating margin is 8.0%, −6.0 pp against the same quarter a year ago. Across 8 fiscal years the operating margin has ranged −6.3%–55.4%.
🚨 Why the margin moved: operating margin went −5.5 pp year on year while gross margin went −19.4 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Kesar India Ltd earned ₹16.0 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹30.0 Cr. The 7-year compound rate is 213.9%. That is 9.4% of the quarter's revenue. The same quarter a year earlier earned ₹0.0 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹16.0 Cr, null year on year. On the full year, FY26 printed ₹30.0 Cr (+57.9%), and the 7-year compound rate is 213.9%.
Pace comparison, last four quarters: profit +402.0% vs revenue +379.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −212% of Kesar India Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−128 Cr of operating cash against ₹30.0 Cr of profit. After ₹9.0 Cr of capital spending, ₹−137 Cr was left as free cash.
FY26: operating cash of ₹−128 Cr against reported profit of ₹30.0 Cr, leaving free cash of ₹−137 Cr after ₹9.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −212% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −212%: the cash cycle stretched 166 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 166 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Kesar India Ltd's cash conversion cycle runs 185 days in FY26, up from 19 days in FY21. Capital spending ran ₹12.0 Cr over the last 3 years. At FY26 sales of ₹176 Cr each day of that cycle holds about ₹0.5 Cr, so roughly ₹89.0 Cr sits inside the business at any moment.
FY26: debtors at 124 days, inventory at 412 days — roughly 13.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 185 days, looser than FY21's 19.
The full loop: cash goes out to suppliers and production on day 0; stock waits 412 days to sell; customers pay about 124 days after that; and suppliers themselves are paid at 351 days — netting out to the 185-day cycle.
In money terms: at FY26 sales of ₹176 Cr, each day of the cycle holds about ₹0.5 Cr — so the 185-day loop keeps roughly ₹89.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹12.0 Cr over the last 3 fiscal years against ₹4.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Kesar India Ltd earns a ROCE of 23% in FY26. That is up from a trough of 1% in FY21. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 17.0% net margin on 0.40× asset turns.
FY26 ROCE is 23%, recovered from a FY21 trough of 1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 17.0% net margin × 0.40× asset turns × 1.76× balance-sheet leverage ≈ 12.0% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Kesar India Ltd carries ₹44.0 Cr of borrowings against ₹250 Cr of equity in FY26, a debt-to-equity of 0.18. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹2.6 Cr to ₹44.0 Cr. Capital spending ran ₹12.0 Cr across the last 3 of those years.
FY26: borrowings of ₹44.0 Cr against equity of ₹250 Cr — a debt-to-equity of 0.18. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹2.6 Cr to ₹44.0 Cr while capital spending ran ₹12.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 4.6 points of Kesar India Ltd over 8 quarters, the biggest move on the register. That takes promoters to 70.4% of the company. Foreign institutions moved −3.1 points over the same window, to 15.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −4.6 points over 8 quarters to 70.4%; Foreign institutions: −3.1 points over 8 quarters to 15.3%.
🚨 Why the register moved: promoters drove it (−4.6 points), alongside foreign institutions (−3.1 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Kesar India Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Arihant Foundations & Housing LtdARIHANT | 65.6/100Favorable setup81% evidence | TURNING | 20.9/35 Revenue 88.8% · PAT 38.8% · OPM change 1 pp 95% evidence | 19.5/25 ROCE 17.5% · OPM 27% 95% evidence | 11.2/20 P/E 15.3× · PEG — 50% evidence | 14.0/20 RS sector 10.4% · RS bench 1.1% · 1Y -17.7%4 of 10 weeks ahead 70% evidence |
| Exact sum: 20.9 + 19.5 + 11.2 + 14 = 65.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Arvind SmartSpaces LtdARVSMART | 63.3/100Mixed-positive evidence82% evidence | TURNING | 20.5/35 Revenue 5.3% · PAT 48% · OPM change 28 pp 95% evidence | 16.6/25 ROCE 12.9% · OPM 49% 76% evidence | 10.2/20 P/E 16.3× · PEG — 50% evidence | 16.0/20 RS sector 8.1% · RS bench 8% · 1Y 9.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 16.6 + 10.2 + 16 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Eldeco Housing & Industries LtdELDEHSG | 62.1/100Mixed-positive evidence81% evidence | ASLEEP | 27.7/35 Revenue 38.1% · PAT 100% · OPM change 25 pp 95% evidence | 14.0/25 ROCE 7.7% · OPM 36% 95% evidence | 7.0/20 P/E 20.6× · PEG — 50% evidence | 13.4/20 RS sector 28.2% · RS bench -11.2% · 1Y 4.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 27.7 + 14 + 7 + 13.4 = 62.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Ashiana Housing LtdASHIANA | 61.6/100Mixed-positive evidence100% evidence | FADING | 29.3/35 Revenue 37% · PAT 100% · OPM change 3 pp 100% evidence | 13.9/25 ROCE 14.4% · OPM 7% 100% evidence | 5.5/20 P/E 30.8× · PEG 4.68 100% evidence | 12.9/20 RS sector 9.3% · RS bench 9.4% · 1Y 15.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 29.3 + 13.9 + 5.5 + 12.9 = 61.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Raymond LtdRAYMOND | 57.9/100Mixed-positive evidence75% evidence | LEADER | 18.8/35 Revenue 13.5% · PAT -80% · OPM change 3 pp 95% evidence | 9.3/25 ROCE 3.1% · OPM 13% 76% evidence | 10.0/20 P/E 25.2× · PEG — 15% evidence | 19.8/20 RS sector 25% · RS bench 24.2% · 1Y 2.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 9.3 + 10 + 19.8 = 57.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6PVP Ventures LtdPVP | 56.2/100Mixed-positive evidence72% evidence | TURNING | 22.5/35 Revenue 100% · PAT 100% · OPM change 0 pp 71% evidence | 6.6/25 ROCE 6.2% · OPM 29% 95% evidence | 8.9/20 P/E 60.4× · PEG — 15% evidence | 18.2/20 RS sector 15.1% · RS bench 15.1% · 1Y 85.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 6.6 + 8.9 + 18.2 = 56.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7AGI Infra LtdAGIIL | 55.0/100Mixed-positive evidence93% evidence | ASLEEP | 19.2/35 Revenue 3.8% · PAT 43.1% · OPM change 9 pp 100% evidence | 18.9/25 ROCE 20.1% · OPM 42% 100% evidence | 10.5/20 P/E 36.9× · PEG 1.25 65% evidence | 6.4/20 RS sector -2.1% · RS bench -1.9% · 1Y 41.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 18.9 + 10.5 + 6.4 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Kesar India Ltdthis page543542 | 54.0/100Mixed-positive evidence67% evidence | ASLEEP | 14.7/35 Revenue 91.9% · PAT 12.6% · OPM change -6 pp 71% evidence | 17.3/25 ROCE 23.4% · OPM 8% 76% evidence | 8.8/20 P/E 84.6× · PEG — 15% evidence | 13.2/20 RS sector 15.1% · RS bench 16% · 1Y 88.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 17.3 + 8.8 + 13.2 = 54 · Decision use: Price leads the evidence: RS versus the benchmark is 16%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9Suraj Estate Developers LtdSURAJEST | 53.1/100Mixed-positive evidence87% evidence | BASING | 13.2/35 Revenue 4% · PAT 1.1% · OPM change 0 pp 95% evidence | 17.7/25 ROCE 14.5% · OPM 37% 95% evidence | 14.1/20 P/E 11.2× · PEG — 50% evidence | 8.1/20 RS sector -11.3% · RS bench -11.7% · 1Y -24.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 17.7 + 14.1 + 8.1 = 53.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 10Ganesh Housing LtdGANESHHOU | 52.3/100Mixed-positive evidence100% evidence | BREAKING OUT | 4.3/35 Revenue -28.6% · PAT -54.1% · OPM change -46 pp 100% evidence | 18.1/25 ROCE 18.8% · OPM 39% 100% evidence | 12.7/20 P/E 26.3× · PEG 0.31 100% evidence | 17.2/20 RS sector 8.4% · RS bench 8.1% · 1Y -2.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 4.3 + 18.1 + 12.7 + 17.2 = 52.3 · Decision use: Price leads the evidence: RS versus the benchmark is 8.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Puravankara LtdPURVA | 52.2/100Mixed-positive evidence61% evidence | BASING | 25.3/35 Revenue 100% · PAT 100% · OPM change 9 pp 71% evidence | 11.3/25 ROCE 11.2% · OPM 22% 76% evidence | 9.5/20 P/E 32.3× · PEG — 15% evidence | 6.1/20 RS sector -13.6% · RS bench -7.8% · 1Y -18.2%5 of 10 weeks ahead 70% evidence |
| Exact sum: 25.3 + 11.3 + 9.5 + 6.1 = 52.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.6% and the one-year return is -18.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Capacite Infraprojects LtdCAPACITE | 51.5/100Mixed-positive evidence81% evidence | BASING | 15.5/35 Revenue 12.4% · PAT -5.6% · OPM change -1 pp 95% evidence | 15.3/25 ROCE 15.5% · OPM 16% 95% evidence | 14.0/20 P/E 9.8× · PEG — 50% evidence | 6.7/20 RS sector -7.6% · RS bench -15.8% · 1Y -26.5%2 of 10 weeks ahead 70% evidence |
| Exact sum: 15.5 + 15.3 + 14 + 6.7 = 51.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Sunteck Realty LtdSUNTECK | 51.0/100Mixed-positive evidence93% evidence | ASLEEP | 26.1/35 Revenue 55.5% · PAT 31.1% · OPM change 10 pp 100% evidence | 8.3/25 ROCE 7.5% · OPM 35% 100% evidence | 13.4/20 P/E 20.6× · PEG 0.87 65% evidence | 3.2/20 RS sector -20.6% · RS bench -20.7% · 1Y -22.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 26.1 + 8.3 + 13.4 + 3.2 = 51 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.6% and the one-year return is -22.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 14Ajmera Realty & Infra India LtdAJMERA | 51.0/100Mixed-positive evidence82% evidence | ASLEEP | 21.8/35 Revenue 43.3% · PAT 23.5% · OPM change -1 pp 95% evidence | 16.5/25 ROCE 14.3% · OPM 29% 76% evidence | 9.8/20 P/E 15× · PEG — 50% evidence | 2.9/20 RS sector -25.2% · RS bench -25.6% · 1Y -30.8%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 16.5 + 9.8 + 2.9 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Suratwwala Business Group LtdSBGLP | 50.4/100Thin evidence · provisional56% evidence | 18.4/35 Revenue 100% · PAT 100% · OPM change 45 pp 40% evidence | 12.7/25 ROCE 12.4% · OPM 37% 71% evidence | 14.1/20 P/E 16.8× · PEG — 50% evidence | 5.2/20 RS sector -13.9% · RS bench -14.8% · 1Y -25.8%2 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 18.4 + 12.7 + 14.1 + 5.2 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Geecee Ventures LtdGEECEE | 49.9/100Mixed-negative evidence87% evidence | BREAKING OUT | 12.1/35 Revenue -6.5% · PAT 20% · OPM change -24.9 pp 95% evidence | 10.0/25 ROCE 6.3% · OPM 28.7% 95% evidence | 9.9/20 P/E 17× · PEG — 50% evidence | 17.9/20 RS sector 11.8% · RS bench 11.5% · 1Y 1.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 10 + 9.9 + 17.9 = 49.9 · Decision use: Price leads the evidence: RS versus the benchmark is 11.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 17Kolte Patil Developers LtdKOLTEPATIL | 48.8/100Mixed-negative evidence78% evidence | TURNING | 15.1/35 Revenue 7.8% · PAT 47.1% · OPM change 53 pp 74% evidence | 7.0/25 ROCE -0.3% · OPM 21% 100% evidence | 13.7/20 P/E 34.1× · PEG 0.74 65% evidence | 13.0/20 RS sector 1.1% · RS bench 20.6% · 1Y 18.3%3 of 10 weeks ahead 70% evidence |
| Exact sum: 15.1 + 7 + 13.7 + 13 = 48.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 18Shriram Properties LtdSHRIRAMPPS | 45.9/100Mixed-negative evidence87% evidence | ASLEEP | 19.0/35 Revenue 37% · PAT 13.6% · OPM change -12.9 pp 95% evidence | 9.1/25 ROCE 8% · OPM -3.9% 95% evidence | 12.9/20 P/E 14.6× · PEG — 50% evidence | 4.9/20 RS sector -9% · RS bench -9.2% · 1Y -11.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 9.1 + 12.9 + 4.9 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Valor Estate LtdDBREALTY | 41.2/100Mixed-negative evidence93% evidence | ASLEEP | 23.6/35 Revenue -49.5% · PAT 100% · OPM change 24.4 pp 100% evidence | 6.5/25 ROCE 1.6% · OPM 20.8% 100% evidence | 4.3/20 P/E 515.6× · PEG 4.19 65% evidence | 6.8/20 RS sector -11.6% · RS bench -12.2% · 1Y -37%9 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 6.5 + 4.3 + 6.8 = 41.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11.6% and the one-year return is -37%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 20Omaxe LtdOMAXE | 39.9/100Mixed-negative evidence63% evidence | TURNING | 13.4/35 Revenue -8.3% · PAT 29.6% · OPM change 61.9 pp 71% evidence | 2.3/25 ROCE -110% · OPM 1.8% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.2/20 RS sector 4% · RS bench 22% · 1Y 7.3%2 of 10 weeks ahead 70% evidence |
| Exact sum: 13.4 + 2.3 + 10 + 14.2 = 39.9 · Decision use: Price leads the evidence: RS versus the benchmark is 22%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 21Keystone Realtors LtdRUSTOMJEE | 39.3/100Mixed-negative evidence76% evidence | ASLEEP | 17.4/35 Revenue 52.6% · PAT -26.8% · OPM change 12.7 pp 95% evidence | 10.1/25 ROCE 4.7% · OPM 17% 76% evidence | 6.4/20 P/E 39.9× · PEG — 50% evidence | 5.4/20 RS sector -11.6% · RS bench -23.5% · 1Y -36.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.4 + 10.1 + 6.4 + 5.4 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Hubtown LtdHUBTOWN | 38.4/100Mixed-negative evidence77% evidence | ASLEEP | 13.5/35 Revenue 29.1% · PAT -12.2% · OPM change -4 pp 100% evidence | 9.5/25 ROCE 9.5% · OPM 18% 100% evidence | 9.7/20 P/E 28.2× · PEG — 15% evidence | 5.7/20 RS sector -10.6% · RS bench -24.4% · 1Y -44.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.5 + 9.5 + 9.7 + 5.7 = 38.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Hemisphere Properties India LtdHEMIPROP | 36.8/100Thin evidence · provisional56% evidence | ASLEEP | 10.3/35 Revenue -4.2% · PAT -46.1% · OPM change -134.2 pp 74% evidence | 4.8/25 ROCE -1.1% · OPM — 64% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.7/20 RS sector 6.5% · RS bench -7.6% · 1Y 0.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 10.3 + 4.8 + 10 + 11.7 = 36.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Peninsula Land LtdPENINLAND | 32.3/100Adverse evidence69% evidence | BASING | 11.5/35 Revenue -50.7% · PAT -80% · OPM change -43.7 pp 71% evidence | 6.7/25 ROCE 4.9% · OPM -19.4% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.1/20 RS sector -33.3% · RS bench -33.9% · 1Y -58.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.5 + 6.7 + 10 + 4.1 = 32.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25SignatureGlobal India LtdSIGNATURE | 29.6/100Adverse evidence90% evidence | ASLEEP | 13.2/35 Revenue -23% · PAT 100% · OPM change -11.8 pp 95% evidence | 4.0/25 ROCE 2.6% · OPM -8% 95% evidence | 7.7/20 P/E 10.9× · PEG 3.94 65% evidence | 4.7/20 RS sector -15.7% · RS bench -15.9% · 1Y -27.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 4 + 7.7 + 4.7 = 29.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Laxmi Goldorna House LtdLGHL | 27.9/100Adverse evidence80% evidence | ASLEEP | 8.6/35 Revenue 12.4% · PAT -80% · OPM change -6 pp 95% evidence | 10.3/25 ROCE 10.1% · OPM 12.1% 95% evidence | 8.5/20 P/E 563× · PEG — 15% evidence | 0.5/20 RS sector -34.5% · RS bench -34.7% · 1Y -35.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.6 + 10.3 + 8.5 + 0.5 = 27.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Kesar India Ltd's share price today?
Kesar India Ltd trades at ₹1,266, +94.8% over the past year. The company is valued at ₹3,956 Cr. The stock sits at 99% of its 52-week range of ₹711–₹1,269, +12.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 49 weeks in. — as of 14 August 2026.
What were Kesar India Ltd's latest quarterly results?
Kesar India Ltd reported revenue of ₹171 Cr and net profit of ₹16.0 Cr for the Jun 26 quarter. Earnings per share were ₹5.31. The operating margin was 8.0%, 6.0 pp lower than a year earlier. — as of 14 August 2026.
What is Kesar India Ltd's revenue?
Kesar India Ltd reported revenue of ₹171 Cr in the Jun 26 quarter, +1,040.0% year on year. For the full FY26 fiscal year, revenue was ₹176 Cr (+63.0%). Over the last 7 years revenue compounded at 165.4% a year. — as of 14 August 2026.
What is Kesar India Ltd's profit?
Kesar India Ltd earned ₹16.0 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹30.0 Cr. The operating margin ran 8.0% in the latest quarter. — as of 14 August 2026.
What is Kesar India Ltd's market cap?
Kesar India Ltd's market capitalisation is ₹3,956 Cr at a share price of ₹1,266. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Kesar India Ltd's P/E ratio?
Kesar India Ltd trades at a P/E of 84.6×, at the 21st percentile of its own 2-year range, against a long-run median of 118.8×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Kesar India Ltd pay a dividend?
No — Kesar India Ltd has recorded a dividend payout of 0% of profit in each of its last 8 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 14 August 2026.
Is Kesar India Ltd overvalued?
On its own history, Kesar India Ltd looks cheap: its P/E of 84.6× has been cheaper only 21% of the time in 2 years (long-run median 118.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
How is Kesar India Ltd performing?
Kesar India Ltd is in a confirmed uptrend, 49 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
Is Kesar India Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 49 of stage 2), trading +12.2% versus its 200-day average and at 99% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Kesar India Ltd beating the market?
Not lately — on a trailing-13-week view Kesar India Ltd is currently behind the NIFTY 500 (4 weeks and counting; last ahead the week of 2026-07-17), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 4.1 years the stock moved +5,040% against the NIFTY 500's +67% — ahead of the index over the full window. — as of 14 August 2026.
Will Kesar India Ltd's share price go up?
This page publishes no price forecast for Kesar India Ltd. What it measures instead: the share price is ₹1,266, the price is in a confirmed uptrend 49 weeks in. Its P/E of 84.6× sits at the 21st percentile of its own 2-year range. — as of 14 August 2026.
Who owns Kesar India Ltd?
Promoters hold 70.4% of Kesar India Ltd, foreign institutions 15.3%, domestic institutions null% and the public 14.3% (latest quarter). The biggest move on the register over the last two years: Promoters cut 4.6 points over 8 quarters. — as of 14 August 2026.
Does Kesar India Ltd have too much debt?
No — Kesar India Ltd's debt-to-equity is 0.18, and operating profit covers the interest bill 11×. FY26 borrowings were ₹44.0 Cr against equity of ₹250 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is Kesar India Ltd's capex?
Kesar India Ltd spent ₹12.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹9.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Kesar India Ltd's cash flow?
Kesar India Ltd consumed ₹128 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−137 Cr). Operating cash was negative while the company reported a profit of ₹30.0 Cr. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is Kesar India Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: Kesar India Ltd consumed cash while reporting profit. In FY26, operating cash was ₹−128 Cr against reported profit of ₹30.0 Cr. Cash-flow resolution is annual — as of 14 August 2026.
Where is Kesar India Ltd in its business cycle?
Kesar India Ltd's FY26 operating margin was 24.0%, against a 8-year band of −6.3%–55.4%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 8.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Kesar India Ltd story?
The sharpest disagreement: the price moved +94.8% in a year while annual EPS moved +33.6% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Kesar India Ltd a stock worth studying right now?
This is not investment advice. The machine read: Kesar India Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.